Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Greenwich LifeSciences, Inc. (GLSI)

Compare
9.74
+0.42
+(4.50%)
As of 3:32:13 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
10,763.69
9,327.87
8,040.25
4,597.94
1,863.79
Operating Income
-10,763.69
-9,327.87
-8,040.25
-4,597.94
-1,863.79
Net Non Operating Interest Income Expense
268.36
436.06
215.02
27.37
0.83
Pretax Income
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Net Income Common Stockholders
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Diluted NI Available to Com Stockholders
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Basic EPS
-0.81
-0.69
-0.61
-0.35
-0.20
Diluted EPS
-0.81
-0.69
-0.61
-0.35
-0.20
Basic Average Shares
12,939.58
12,848.17
12,913.85
12,944.13
9,499.16
Diluted Average Shares
12,939.58
12,848.17
12,913.85
12,944.13
9,499.16
Total Operating Income as Reported
-10,763.69
-9,327.87
-8,040.25
-4,597.94
-1,863.79
Total Expenses
10,763.69
9,327.87
8,040.25
4,597.94
1,863.79
Net Income from Continuing & Discontinued Operation
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Normalized Income
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Interest Income
268.36
436.06
215.02
27.37
0.83
Net Interest Income
268.36
436.06
215.02
27.37
0.83
EBIT
-10,763.69
-9,327.87
-8,040.25
-4,597.94
-1,863.79
EBITDA
-10,760.08
-9,324.25
-8,036.64
-4,594.33
-1,860.19
Reconciled Depreciation
3.61
3.61
3.61
3.61
3.61
Net Income from Continuing Operation Net Minority Interest
-10,495.33
-8,891.80
-7,825.24
-4,570.58
-1,862.96
Normalized EBITDA
-10,760.08
-9,324.25
-8,036.64
-4,594.33
-1,860.19
12/31/2020 - 9/25/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SLS SELLAS Life Sciences Group, Inc.
1.1250
+1.35%
 
ATOS Atossa Therapeutics, Inc.
0.6300
+6.83%
 
CMPX Compass Therapeutics, Inc.
1.6600
+0.60%
 
IMMP Immutep Limited
1.4500
+2.84%
 
INMB INmune Bio, Inc.
7.37
+9.44%
 
QURE uniQure N.V.
8.71
+1.58%
 
PRTA Prothena Corporation plc
10.22
+5.47%
 
FDMT 4D Molecular Therapeutics, Inc.
2.6050
+0.58%
 
BCTX BriaCell Therapeutics Corp.
4.2700
+6.75%
 
SWTX SpringWorks Therapeutics, Inc.
35.72
+3.75%